Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$942K Buy
+2,600
New +$890K 0.09% 72
2025
Q4
Sell
-3,000
Closed -$847K 73
2025
Q3
$847K Sell
3,000
-1,000
-25% -$290K 0.11% 58
2025
Q2
$1.12M Buy
+4,000
New +$1.13M 0.17% 53
2025
Q1
Sell
-4,500
Closed -$1.17M 55
2024
Q4
$1.17M Buy
+4,500
New +$1.34M 0.2% 38
2023
Q3
Sell
-9,200
Closed -$2.04M 68
2023
Q2
$2.04M Buy
9,200
+600
+7% +$139K 0.71% 27
2023
Q1
$2.08M Buy
+8,600
New +$2.11M 0.71% 25
2021
Q4
Sell
-24,628
Closed -$5.24M 53
2021
Q3
$5.24M Buy
24,628
+20,628
+516% +$4.75M 2.02% 18
2021
Q2
$975K Buy
+4,000
New +$984K 0.43% 27
2021
Q1
Sell
-100
Closed -$22K 47
2020
Q4
$22K Buy
+100
New +$23.1K 0.01% 60

Other funds holding AMGN

B&D White Capital Company's AMGN Position: Q2 2026 in Review

B&D White Capital Company opened a new position in Amgen (AMGN) in Q2 2026: 2,600 shares worth $942K. The stake represents 0.09% of the portfolio and ranks #72 among its holdings. This is a return to the name: B&D White Capital Company previously reported a position in AMGN as recently as Q3 2025.

B&D White Capital Company first reported a position in AMGN in Q4 2020 and has held it in 9 quarters since. The position peaked at $5.24M in Q3 2021. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • B&D White Capital Company held 2,600 shares of Amgen worth $942K as of Q2 2026.
  • Amgen was a new B&D White Capital Company position in Q2 2026.
  • Amgen made up 0.09% of B&D White Capital Company's portfolio in Q2 2026, its #72 holding.
  • B&D White Capital Company first reported a position in Amgen in Q4 2020 and has held it in 9 quarters since.
  • B&D White Capital Company's Amgen position peaked at $5.24M in Q3 2021.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on B&D White Capital Company's 13F filing for Q2 2026, filed 31 Jul 2026.